Next Article in Journal
Preservation of Xinyu Tangerines with an Edible Coating Using Ficus hirta Vahl. Fruits Extract-Incorporated Chitosan
Next Article in Special Issue
Triterpene Derivatives as Relevant Scaffold for New Antibiofilm Drugs
Previous Article in Journal
Impaired CENP-E Function Renders Large Chromosomes More Vulnerable to Congression Failure
Previous Article in Special Issue
A Review on Bioactivities of Tobacco Cembranoid Diterpenes
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessArticle
Biomolecules 2019, 9(2), 45; https://doi.org/10.3390/biom9020045

Anti-Tumor Activity of Cembranoid-Type Diterpenes Isolated from Nicotiana tabacum L.

Tobacco Research Institute of Chinese Academy of Agricultural Sciences, Qingdao 266101, China
*
Authors to whom correspondence should be addressed.
Received: 3 December 2018 / Revised: 17 January 2019 / Accepted: 17 January 2019 / Published: 28 January 2019
(This article belongs to the Special Issue Evaluation and formulation of Bioactive Terpenes)
Full-Text   |   PDF [3312 KB, uploaded 2 February 2019]   |  

Abstract

Recently, the incidence of hepatocellular carcinoma has increased worldwide. Cembranoid-type diterpenes (CBDs) from tobacco exhibit good antimicrobial, antitumor, and neuroprotective activities. Therefore, in this study, we isolated CBDs from Nicotiana tabacum L. and evaluated their antitumor activity against hepatoma cell lines. Particularly, the anti-tumor activity of α-2,7,11-cyprotermine-4,6-diol (α-CBD) was investigated against HepG2, SMMC-7721, and HL-7702 cells. The MTT assay revealed that α-CBD reduced the formation of cell clones and inhibited the proliferation of hepatocellular carcinoma cells. Morphological observations showed that α-CBD altered cell morphology and membrane permeability before inducing apoptosis. To further explore the antitumor mechanism of α-CBD, flow cytometry and transcriptome analysis were performed using HepG2 cells. The results showed that the number of HepG2 cells increased from 10.4% to 29.8%, indicating that α-CBD inhibits the proliferation of hepatocellular carcinoma cells in the S phase. The gene expression analysis of HepG2 cells treated with α-CBD showed 3068 genes with altered expression, among which 1289 were upregulated and 1779 were downregulated. Apoptosis induced by these differentially expressed genes might be mediated by the p53-PUMA, PI3K-Akt, and IL-1-NF-κB-IAP pathways. Comprehensively, our study shows that α-CBD isolated from N. tabacum L. can be potentially used as a natural antitumor agent. View Full-Text
Keywords: antitumor activity; α-cembratriene-diol; cytological observation; Nicotiana tabacum L.; transcriptome antitumor activity; α-cembratriene-diol; cytological observation; Nicotiana tabacum L.; transcriptome
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Yuan, X.-L.; Mao, X.-X.; Du, Y.-M.; Yan, P.-Z.; Hou, X.-D.; Zhang, Z.-F. Anti-Tumor Activity of Cembranoid-Type Diterpenes Isolated from Nicotiana tabacum L.. Biomolecules 2019, 9, 45.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top